PRAX vs REG · rev $8.6M vs P/E 34, $12.93B cap
Praxis Precision Medicines Inc (PRAX) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Praxis Precision Medicines Inc (PRAX) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported PRAX revenue for 2024-12-31 was $8.6M. Net income was -$58.7M. Revenue was up 249.5% from 2023-12-31 to 2024-12-31. PRAX currently screens at market cap $7.38B.
REG does not have a complete income-statement cache yet.
PRAX currently screens at market cap $7.38B. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the PRAX and REG stock pages for the full models.
Not investment advice.